Ultralife 관리

Michael Manna 의 보수는 Ultralife 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Sep 30 2024	n/a	n/a	US$9m
Jun 30 2024	n/a	n/a	US$10m
Mar 31 2024	n/a	n/a	US$10m
Dec 31 2023	US$779k	US$377k	US$7m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	US$3m
Mar 31 2023	n/a	n/a	-US$297k
Dec 31 2022	US$317k	US$241k	-US$119k

보상 대 시장: Michael 의 총 보상 ($USD 779.04K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 653.78K ).

보상과 수익: Michael 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Michael Manna (54 yo)

2yrs

테뉴어

US$779,043

보상

Mr. Michael E. Manna serves as President, Chief Executive Officer & Director at Ultralife Corporation since November 22, 2022. He was President of Battery & Energy Products at Ultralife Corporation since S...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Michael Manna	President	2yrs	US$779.04k	0.11% $ 131.9k
Bradford Whitmore	Chair of the Board of Directors	17.4yrs	US$103.00k	34.16% $ 40.8m
Thomas Saeli	Independent Director	14.7yrs	US$100.42k	0.48% $ 574.4k
Robert Shaw	Independent Director	14.4yrs	US$99.39k	0.39% $ 468.5k
Janie Goddard	Independent Director	1.8yrs	US$82.79k	0.026% $ 31.5k

14.4yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: ULBI 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 14.4 년).

Ultralife 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Independent Chairman recently bought US$112k worth of stock

Independent Chairman recently bought US$398k worth of stock

Recent updates

Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024

Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million.

Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now?

Ultralife: I Bought The Dip; Here Comes The Growth

Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They Seem

Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024

Ultralife Corporation Is Attractive Here

Ultralife Corporation, Annual General Meeting, Jul 16, 2024

Investor sentiment improves as stock rises 17%

Price target decreased by 7.7% to US$12.00

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation: Ready To Surge

These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well

Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement

Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022)

Investor sentiment improves as stock rises 15%

Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price

New major risk - Revenue and earnings growth

Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024

Independent Chairman recently bought US$111k worth of stock

Independent Chairman recently bought US$181k worth of stock

Independent Chairman recently bought US$99k worth of stock

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)?

Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023

Investor sentiment improves as stock rises 18%

Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital

Independent Chairman recently bought US$112k worth of stock

Investor sentiment improves as stock rises 27%

Consensus revenue estimates increase by 12%

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023

Independent Chairman recently bought US$398k worth of stock

Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt

Independent Chairman recently bought US$146k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 19, 2023

Independent Chairman recently bought US$117k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$122k worth of stock

Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021)

Independent Chairman recently bought US$279k worth of stock

Ultralife Corporation Announces Executive Changes

Price target increased to US$12.00

Insufficient new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022

Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt

Ultralife secures $7.5M communications systems contract

Independent Chairman recently bought US$158k worth of stock

Independent Chairman recently bought US$467k worth of stock

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Ultralife receives $4.6M communications systems VAA order

Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022

Independent Chairman recently bought US$219k worth of stock

Ultralife Corporation, Annual General Meeting, Jul 20, 2022

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022

Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Independent Chairman recently bought US$245k worth of stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus revenue estimates fall by 14%

Investor sentiment improved over the past week

Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million.